Treatment of amyotrophic lateral sclerosis
US10167263B2 · kind B2 · utility
0Cited by
3References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 20, 2009 |
| Grant date | Jan 1, 2019 |
| Priority date | — |
| Expiry date | Apr 3, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to the identification of compounds and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the provided compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.